These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34090807)

  • 21. Preoperative Alkaline Phosphatase-adjusted CA19-9 as a Superior Prognosticator for Extrahepatic Biliary Tract Cancer With Jaundice.
    Ikuta S; Aihara T; Nakajima T; Kasai M; Yamanaka N
    Cancer Diagn Progn; 2022; 2(5):569-575. PubMed ID: 36060020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NARCA: A novel prognostic scoring system using neutrophil-albumin ratio and Ca19-9 to predict overall survival in palliative pancreatic cancer.
    Tingle SJ; Severs GR; Goodfellow M; Moir JA; White SA
    J Surg Oncol; 2018 Sep; 118(4):680-686. PubMed ID: 30196571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ratio of CA19-9 Level to Total Tumor Volume as a Prognostic Predictor of Pancreatic Carcinoma After Curative Resection.
    Xu J; Lyu S; Zhao Y; Zhang X; Liu Z; Zhao X; He Q
    Technol Cancer Res Treat; 2022; 21():15330338221078438. PubMed ID: 35138217
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of preoperative biliary drainage on liver function changes in patients with malignant obstructive jaundice in the low bile duct before and after pancreaticoduodenectomy].
    Chen D; Liang LJ; Peng BG; Zhou Q; Li SQ; Tang D; Huang L; Huang JF
    Ai Zheng; 2008 Jan; 27(1):78-82. PubMed ID: 18184470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in CRP and CA19-9 during Preoperative Oncological Therapy Predict Postoperative Survival in Pancreatic Ductal Adenocarcinoma.
    Nurmi AM; Mustonen H; Haglund C; Seppänen H
    Oncology; 2021; 99(11):686-698. PubMed ID: 34412062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative serum carbohydrate antigen 125 level is an independent negative prognostic marker for overall survival in colorectal cancer.
    Yang XQ; Li Y; Chen C; Peng CW; Liu SP; Liu Y
    Med Oncol; 2011 Sep; 28(3):789-95. PubMed ID: 20373053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Normalization of CA19-9 following resection for pancreatic ductal adenocarcinoma is not tantamount to being cured?
    Chen T; Zhang MG; Yu XJ; Liu L
    Asian Pac J Cancer Prev; 2015; 16(2):661-6. PubMed ID: 25684504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive Early Recurrence Factors of Preoperative Clinicophysiological Findings in Pancreatic Cancer.
    Suzuki S; Shimoda M; Shimazaki J; Maruyama T; Oshiro Y; Nishida K; Sahara Y; Nagakawa Y; Tsuchida A
    Eur Surg Res; 2018; 59(5-6):329-338. PubMed ID: 30453288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ABO blood type, smoking status, other risk factors and prognosis of pancreatic ductal adenocarcinoma.
    Li SS; Zhou CY; Liao R; Xiong L; Weng NN; Zhao YQ; Mason C; Gou HF; Yi C; Zhu Q
    Medicine (Baltimore); 2020 Apr; 99(14):e19413. PubMed ID: 32243360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative plasma D-dimer independently predicts survival in patients with pancreatic ductal adenocarcinoma undergoing radical resection.
    Chen H; Li F; Zou S; Xie J; Zhang J; Deng X; Chen H; Shen B
    World J Surg Oncol; 2021 Jun; 19(1):166. PubMed ID: 34107980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of preoperative CEA and CA19-9 improves prediction outcomes in patients with resectable pancreatic adenocarcinoma: results from a large follow-up cohort.
    Zhou G; Liu X; Wang X; Jin D; Chen Y; Li G; Li C; Fu D; Xu W; Wang X
    Onco Targets Ther; 2017; 10():1199-1206. PubMed ID: 28280354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stage-Specific Value of Carbohydrate Antigen 19-9 and Carcinoembryonic Antigen Serum Levels on Survival and Recurrence in Pancreatic Cancer: A Single Center Study and Meta-Analysis.
    van Manen L; Groen JV; Putter H; Pichler M; Vahrmeijer AL; Bonsing BA; Mieog JSD
    Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33066393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic immune-inflammation index predicts prognosis of patients with advanced pancreatic cancer.
    Zhang K; Hua YQ; Wang D; Chen LY; Wu CJ; Chen Z; Liu LM; Chen H
    J Transl Med; 2019 Jan; 17(1):30. PubMed ID: 30658662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does Pre-operative Biliary Drainage Influence Long-Term Survival in Patients With Obstructive Jaundice With Resectable Pancreatic Head Cancer?
    Shen Z; Zhang J; Chen H; Wang W; Xu W; Lu X; Zhou Y; Zhao S; Xu Z; Deng X; Wang J; Weng Y; Shen B
    Front Oncol; 2020; 10():575316. PubMed ID: 33042848
    [No Abstract]   [Full Text] [Related]  

  • 35. Dynamic monitoring of serum CEA and CA19-9 predicts the prognosis of postoperative stage II colon cancer.
    Wang R; Xu B; Sun M; Pang X; Wang X; Zhu J; Lian J; Lu H
    Eur J Surg Oncol; 2023 Dec; 49(12):107138. PubMed ID: 37925830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Preoperative Prognostic Scoring System to Predict Prognosis for Resectable Pancreatic Cancer: Who Will Benefit from Upfront Surgery?
    Nakamura T; Asano T; Okamura K; Tsuchikawa T; Murakami S; Kurashima Y; Ebihara Y; Noji T; Nakanishi Y; Tanaka K; Shichinohe T; Hirano S
    J Gastrointest Surg; 2019 May; 23(5):990-996. PubMed ID: 30242645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative CA19-9 and GGT ratio as a prognostic indicator in ampullary carcinoma.
    Chen RQ; Zhang ZL; Jia YM; Chen RX; Peng L
    BMC Gastroenterol; 2023 Mar; 23(1):72. PubMed ID: 36915042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outcomes of pancreatic ductal adenocarcinoma.
    Xu HX; Liu L; Xiang JF; Wang WQ; Qi ZH; Wu CT; Liu C; Long J; Xu J; Ni QX; Yu XJ
    Surgery; 2017 Feb; 161(2):373-384. PubMed ID: 27838102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Nomogram for Patients With Pancreatic Ductal Adenocarcinoma of Pancreatic Head After Pancreaticoduodenectomy.
    Zhuang H; Zhou Z; Ma Z; Huang S; Gong Y; Li Z; Liu C; Wang S; Chen B; Zhang C; Hou B
    Clin Med Insights Oncol; 2021; 15():11795549211024149. PubMed ID: 34211308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gamma-glutamyl transpeptidase level is a novel adverse prognostic indicator in human metastatic colorectal cancer.
    He WZ; Guo GF; Yin CX; Jiang C; Wang F; Qiu HJ; Chen XX; Rong RM; Zhang B; Xia LP
    Colorectal Dis; 2013 Aug; 15(8):e443-52. PubMed ID: 23621885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.